Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

39.10
+0.27440.71%
Post-market: 39.100.00000.00%16:10 EDT
Volume:2K
Turnover:85.52K
Market Cap:96.57M
PE:- -
High:39.10
Open:38.94
Low:38.82
Close:38.83
52wk High:39.48
52wk Low:32.44
Shares:2.47M
Float Shares:2.47M
Volume Ratio:0.20
T/O Rate:0.09%
Dividend:0.33
Dividend Rate:0.83%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Ventas (VTR) Gets a Hold from UBS

TIPRANKS
·
Aug 21

Guizhou Unveils 13 Typical Cases of Consumer Rights Violations in Market Regulation Crackdown

Deep News
·
Aug 21

Healthpeak Properties Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 21

Edwards Lifesciences (EW) Stock Looks Above Fair Value As Its 22% Three Year Run Continues

Simply Wall St.
·
Aug 21

AbbVie Targets Next-Gen BOTOX Combo With New Glabellar Lines Study

TIPRANKS
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21

Eli Lilly Revenue Jumps 48% as Mounjaro and Zepbound Sales Reach $14.9B

TradingKey
·
Aug 20

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

WELL Health Retires $70 Million Convertible Debentures Following Notes Offering

TIPRANKS
·
Aug 20

Singapore authorities launch probe into iron ore merchant Radiant World as lenders and traders sever ties

Deep News
·
Aug 20

LabGenomics Lowers Conversion Price on Fifth Tranche of Convertible Bonds

TIPRANKS
·
Aug 20

7 Growth Stocks Holding up in a Tough Market

Dow Jones
·
Aug 20

Gubra H1 FY26 Operating Loss Widens to DKK 122.9 Million; Revenue Drops 95% to DKK 126.3 Million

Reuters
·
Aug 20

Arovella lodges 2026 corporate governance statement and Appendix 4G

TIPRANKS
·
Aug 20

Will Foundayo’s UK GLP‑1 Approval and New R&D Deals Change Eli Lilly's (LLY) Narrative?

Simply Wall St.
·
Aug 20

Amplitude Therapeutics: Lilly to GET Exclusive, Target-Specific Rights to Develop ,Commercialize Licensed Products Directed to Collaboration Targets

THOMSON REUTERS
·
Aug 20

Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying Rna Vaccines for Infectious Diseases

THOMSON REUTERS
·
Aug 20

Amplitude: Initial Programs Target Infectious Diseases with High Unmet Need, with Lilly Retaining Options for up to Two Additional Targets

THOMSON REUTERS
·
Aug 20

Marvel Biosciences Extends Private Placement Access to Quebec Investors

TIPRANKS
·
Aug 20